Your browser doesn't support javascript.
loading
Preliminary study on integration of traditional Chinese medicine and western medicine in patients with coronary heart disease in real world / 中国中药杂志
Artigo em Chinês | WPRIM (Pacífico Ocidental) | ID: wpr-244539
Biblioteca responsável: WPRO
ABSTRACT
<p><b>OBJECTIVE</b>Observe and analyze the informations of western medicine and traditional Chinese medicine in patients with coronary heart disease (CHD), in order to provide reference for clinical treatment.</p><p><b>METHOD</b>Select patients with CHD in diagnosis of the first place in 17 hospitals, drug informations of these patients were analyzed using frequency method and association rules.</p><p><b>RESULT</b>In 84 697 patients,there were 47 564 males and 32 882 females. The median age was 71 years old, 76 172 patients have medicine records, including 278 kinds of western medicine and 331 kinds of traditional Chinese medicine. Aspirin was the most common used western medicine (51 132 patients, 67.08%), followed by isosorbide dinitrate, clopidogrel etc. The most common used traditional Chinese medicine was danhong injection, followed by shuxuetong injection. After classified the drugs, at the forefront of western medicine were antiplatelet drugs, nitrates drugs, statins, beta blockers, calcium antagonists, ACEI; the most used in traditional Chinese medicine was injection of blood-activating and stasis-resolving, followed by oral preparations of blood-activating and stasis-resolving medicine, Fuzheng class oral medicine, purgation medicine etc. After association rules, combination therapy among western medicine was the most common, combination of western medicine with blood-activating and stasis-resolving was very commonly, especially antiplatelet drugs and nitrates drugs.</p><p><b>CONCLUSION</b>Western medicine in the treatment of patients with CHD was in accordance with the guidelines recommend, but with the lower utilization rate. Traditional Chinese medicine has become an important method for the treatment of CHD, promoting blood circulation and removing blood stasis is an important part of traditional Chinese medicine treatment in patients with CHD.</p>
Assuntos
Texto completo: Disponível Base de dados: WPRIM (Pacífico Ocidental) Assunto principal: Medicamentos de Ervas Chinesas / Inibidores da Agregação Plaquetária / Aspirina / Terapia Combinada / Antagonistas Adrenérgicos beta / Inibidores de Hidroximetilglutaril-CoA Redutases / Doença das Coronárias / Usos Terapêuticos / Tratamento Farmacológico / Medicina Tradicional Chinesa Tipo de estudo: Estudo diagnóstico / Guia de prática clínica Limite: Idoso, 80 anos ou mais / Animais / Humanos / Masculino Idioma: Chinês Revista: China Journal of Chinese Materia Medica Ano de publicação: 2014 Tipo de documento: Artigo
Texto completo: Disponível Base de dados: WPRIM (Pacífico Ocidental) Assunto principal: Medicamentos de Ervas Chinesas / Inibidores da Agregação Plaquetária / Aspirina / Terapia Combinada / Antagonistas Adrenérgicos beta / Inibidores de Hidroximetilglutaril-CoA Redutases / Doença das Coronárias / Usos Terapêuticos / Tratamento Farmacológico / Medicina Tradicional Chinesa Tipo de estudo: Estudo diagnóstico / Guia de prática clínica Limite: Idoso, 80 anos ou mais / Animais / Humanos / Masculino Idioma: Chinês Revista: China Journal of Chinese Materia Medica Ano de publicação: 2014 Tipo de documento: Artigo
...